These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24731236)

  • 1. The application of network label propagation to rank biomarkers in genome-wide Alzheimer's data.
    Stokes ME; Barmada MM; Kamboh MI; Visweswaran S
    BMC Genomics; 2014 Apr; 15():282. PubMed ID: 24731236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genetic interactions associated with late-onset Alzheimer's disease.
    Floudas CS; Um N; Kamboh MI; Barmada MM; Visweswaran S
    BioData Min; 2014; 7(1):35. PubMed ID: 25649863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of naive Bayes model averaging to predict Alzheimer's disease from genome-wide data.
    Wei W; Visweswaran S; Cooper GF
    J Am Med Inform Assoc; 2011; 18(4):370-5. PubMed ID: 21672907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEAP: biomarker inference through learning and evaluating association patterns.
    Jiang X; Neapolitan RE
    Genet Epidemiol; 2015 Mar; 39(3):173-84. PubMed ID: 25677188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data mining of high density genomic variant data for prediction of Alzheimer's disease risk.
    Briones N; Dinu V
    BMC Med Genet; 2012 Jan; 13():7. PubMed ID: 22273362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests.
    Nguyen TT; Huang J; Wu Q; Nguyen T; Li M
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S5. PubMed ID: 25708662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random forests on Hadoop for genome-wide association studies of multivariate neuroimaging phenotypes.
    Wang Y; Goh W; Wong L; Montana G;
    BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S6. PubMed ID: 24564704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of genetic predisposition to Alzheimer's disease and related sex disparities.
    Nazarian A; Yashin AI; Kulminski AM
    Alzheimers Res Ther; 2019 Jan; 11(1):5. PubMed ID: 30636644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting the dots: potential of data integration to identify regulatory SNPs in late-onset Alzheimer's disease GWAS findings.
    Rosenthal SL; Barmada MM; Wang X; Demirci FY; Kamboh MI
    PLoS One; 2014; 9(4):e95152. PubMed ID: 24743338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
    Amber S; Zahid S
    Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide variant-based study of genetic effects with the largest neuroanatomic coverage.
    Li J; Liu W; Li H; Chen F; Luo H; Bao P; Li Y; Jiang H; Gao Y; Liang H; Fang S
    BMC Bioinformatics; 2021 Apr; 22(1):223. PubMed ID: 33931008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
    Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
    J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.
    Herrera-Espejo S; Santos-Zorrozua B; Alvarez-Gonzalez P; Martin-Guerrero I; M de Pancorbo M; Garcia-Orad A; Lopez-Lopez E
    Mol Neurobiol; 2021 Jan; 58(1):55-64. PubMed ID: 32892277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAX-rank: a simple and robust genome-wide scan for case-control association studies.
    Li Q; Yu K; Li Z; Zheng G
    Hum Genet; 2008 Jul; 123(6):617-23. PubMed ID: 18491142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.
    Beecham GW; Martin ER; Li YJ; Slifer MA; Gilbert JR; Haines JL; Pericak-Vance MA
    Am J Hum Genet; 2009 Jan; 84(1):35-43. PubMed ID: 19118814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An algorithm for direct causal learning of influences on patient outcomes.
    Rathnam C; Lee S; Jiang X
    Artif Intell Med; 2017 Jan; 75():1-15. PubMed ID: 28363452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression.
    Silver M; Janousova E; Hua X; Thompson PM; Montana G;
    Neuroimage; 2012 Nov; 63(3):1681-94. PubMed ID: 22982105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach.
    Wang XF; Lin X; Li DY; Zhou R; Greenbaum J; Chen YC; Zeng CP; Peng LP; Wu KH; Ao ZX; Lu JM; Guo YF; Shen J; Deng HW
    J Neurol Sci; 2017 Sep; 380():262-272. PubMed ID: 28870582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.